(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 6.48% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Bausch & Lomb's revenue in 2026 is $5,101,000,000.On average, 16 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,962,922,816,920, with the lowest BLCO revenue forecast at $1,870,800,085,440, and the highest BLCO revenue forecast at $2,028,117,365,352. On average, 15 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,071,344,185,508, with the lowest BLCO revenue forecast at $1,962,568,498,722, and the highest BLCO revenue forecast at $2,157,797,825,820.
In 2028, BLCO is forecast to generate $2,182,245,781,482 in revenue, with the lowest revenue forecast at $2,051,148,048,222 and the highest revenue forecast at $2,285,706,695,298.